Effects of Otago and Gaze Stabilization Exercises on Balance, Gait and QOL in Elderly Stroke Patients

NCT ID: NCT06845709

Last Updated: 2025-02-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

46 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-09-01

Study Completion Date

2025-04-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To compare effects of otago exercises and Gaze stabilization exercises on Balance, gait and quality of Life in elderly stroke patients

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Study design will be a randomized clinical trial . Total 46 stroke patients will be recruited from Riphah Rehabilitation center and General hospital, Lahore by using non-probability convenience sampling technique. Patients will be randomized and allocated into two intervention groups based on inclusion and exclusion criteria. Patients in group A will receive Gaze Stabilization Exercises with conventional baseline treatment and group B patients will receive Otago Exercises with conventional baseline treatment. Patients will receive treatment of 40 minutes per session for 5 days a week for 8 weeks. Berg Balance Scale, Dynamic Gait Index and Stroke specific quality of life will be used as assessment tools. Data will be analyzed by using SPSS 26 version.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Balance; Distorted Gait, Hemiplegic Quality of Life

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Patients will be divided in group A will receive Gaze Stabilization Exercises with conventional baseline treatment and group B patients will receive Otago Exercises with conventional baseline treatment. Patients will receive treatment of 40 minutes per session for 5 days a week for 8 weeks.
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

gaze stabilization exercise

Patients in group A will receive Gaze Stabilization Exercises with conventional baseline treatment

Group Type EXPERIMENTAL

gaze stabilization exercise

Intervention Type OTHER

Patients in group A will receive Gaze Stabilization Exercises with conventional baseline treatment

otago exercise

Patients in group B will receive Otago Exercises with conventional baseline treatment.

Group Type ACTIVE_COMPARATOR

otago exercise

Intervention Type OTHER

group B patients will receive Otago Exercises with conventional baseline treatment

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

gaze stabilization exercise

Patients in group A will receive Gaze Stabilization Exercises with conventional baseline treatment

Intervention Type OTHER

otago exercise

group B patients will receive Otago Exercises with conventional baseline treatment

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Had ischemic or haemorrhagic stroke ≤6 months
* Berg Balance Scale (BBS) score between 35 and 45
* Dynamic Gait Index score between 11 and 19
* Mini-mental status exam scores \> 24

Exclusion Criteria

* Participants with severe vision or hearing impairment
* Neurological disorders including epilepsy, Alzheimer's disease, vertigo, Parkinson disease, and stroke, muscular disorders which limit functional activity (OA, RA, etc)
* Medications that affect balance, severe cardiovascular conditions, recent lower limb injury or surgery
* Peripheral vestibular disorder
Minimum Eligible Age

50 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Riphah International University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Dr.Zeest Hashmi, MSNMPT

Role: PRINCIPAL_INVESTIGATOR

Riphah International University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Riphah International University

Islamabad, Fedral, Pakistan

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Pakistan

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Zeest Hashmi, MS NMPT

Role: CONTACT

03224655851

Imran Amjad, PhD

Role: CONTACT

03324390125

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

zeest Hashmi, MS NMPT

Role: primary

03224655851

Imran Amjad, PhD

Role: backup

03324390125

References

Explore related publications, articles, or registry entries linked to this study.

Di Vincenzo O, Luisi MLE, Alicante P, Ballarin G, Biffi B, Gheri CF, Scalfi L. The Assessment of the Risk of Malnutrition (Undernutrition) in Stroke Patients. Nutrients. 2023 Jan 29;15(3):683. doi: 10.3390/nu15030683.

Reference Type BACKGROUND
PMID: 36771390 (View on PubMed)

Mead GE, Sposato LA, Sampaio Silva G, Yperzeele L, Wu S, Kutlubaev M, Cheyne J, Wahab K, Urrutia VC, Sharma VK, Sylaja PN, Hill K, Steiner T, Liebeskind DS, Rabinstein AA. A systematic review and synthesis of global stroke guidelines on behalf of the World Stroke Organization. Int J Stroke. 2023 Jun;18(5):499-531. doi: 10.1177/17474930231156753. Epub 2023 Mar 1.

Reference Type BACKGROUND
PMID: 36725717 (View on PubMed)

Sim J, Shin C. Two stroke education programs designed for older adults. Geriatr Nurs. 2024 Jan-Feb;55:105-111. doi: 10.1016/j.gerinurse.2023.10.014. Epub 2023 Nov 17.

Reference Type BACKGROUND
PMID: 37979469 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

REC/RCR & AHS/24/0237

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.